Source: Genetics in medicine. Unidade: FM
Subjects: AGENTES DOPAMINÉRGICOS, CÉREBRO
ABNT
SAIDA, Ken et al. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals. Genetics in medicine, v. 25, n. 1, p. 90-102, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53033. Acesso em: 17 ago. 2024.APA
Saida, K., Marootain, R., Sengoku, T., Mitani, T., Pagnamenta, A. T., Marafi, D., et al. (2023). Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals. Genetics in medicine, 25( 1), 90-102. doi:10.1016/j.gim.2022.09.010NLM
Saida K, Marootain R, Sengoku T, Mitani T, Pagnamenta AT, Marafi D, Zaki MS, O'Brien TJ, Karimiani EG, Kaiyrzhanov R, Ceroni JRM, Kim CA. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals [Internet]. Genetics in medicine. 2023 ; 25( 1): 90-102.[citado 2024 ago. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53033Vancouver
Saida K, Marootain R, Sengoku T, Mitani T, Pagnamenta AT, Marafi D, Zaki MS, O'Brien TJ, Karimiani EG, Kaiyrzhanov R, Ceroni JRM, Kim CA. Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals [Internet]. Genetics in medicine. 2023 ; 25( 1): 90-102.[citado 2024 ago. 17 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53033